Congenital Short Bowel Syndrome

Watchlist

(log in to enable)

Retrieved

2021-01-23

Source

Orphanet

Trials

—

Genes

FLNA

Drugs

Apraglutide, Human glucagon-like peptide-2 analogue linked to a human immunoglobulin Fc fragment, Insulin human

Apraglutide, Human glucagon-like peptide-2 analogue linked to a human immunoglobulin Fc fragment, Insulin human, L-Glutamine ( ENDARI, NUTRESTORE ), Oxalobacter formigenes strain HC-1, Teduglutide ( GATTEX, REVESTIVE )

Interested in hearing about new therapies?

Congenital short bowel syndrome is a rare intestinal disorder of neonates of unknown etiology. Patients are born with a short small bowel (less than 75 cm in length) that compromises proper intestinal absorption and leads chronic diarrhea, vomiting and failure to thrive.